Cargando…
Recent clinical trials with stem cells to slow or reverse normal aging processes
Aging is associated with a decline in the regenerative potential of stem cells. In recent years, several clinical trials have been launched in order to evaluate the efficacy of mesenchymal stem cell interventions to slow or reverse normal aging processes (aging conditions). Information concerning th...
Autor principal: | Garay, Ricardo P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116573/ https://www.ncbi.nlm.nih.gov/pubmed/37090485 http://dx.doi.org/10.3389/fragi.2023.1148926 |
Ejemplares similares
-
Applying C. elegans to the Industrial Drug Discovery Process to Slow Aging
por: Weinkove, David, et al.
Publicado: (2021) -
Clinical Trials Targeting Aging
por: Nielsen, Johannes Leth, et al.
Publicado: (2022) -
Oocyte aging in comparison to stem cells in mice
por: Nagamatsu, Go
Publicado: (2023) -
An NRF2 Perspective on Stem Cells and Ageing
por: Dodson, Matthew, et al.
Publicado: (2021) -
Proteolysis dysfunction in the process of aging and age-related diseases
por: Frankowska, Natalia, et al.
Publicado: (2022)